Bausch + Lomb wins FDA panel vote for eye implant

04/9/2013 | MassDevice.com (Boston)

A panel of FDA advisers has voted in favor of recommending approval for Bausch + Lomb's Trulign Toric device, designed for patients who have undergone cataract-removal surgery. The posterior chamber intraocular lens is implanted in the eye's capsular bag to visually correct postoperative refractive astigmatism and aphakia in adult patients.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX